Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1785 | Thyroid cancer | ICEECE2012

Dual specificity phosphatase 5 (DUSP5), a specific negative feedback regulator of ERK signaling, is controlled by serum response factor (SRF) and Elk-1 transcription factors

Buffet C. , Garcia C. , Catelli M. , Hecale-Perlemoine K. , Bertagna X. , Bertherat J. , Groussin L.

Mitogen-activated protein kinase (MAPK) pathway abnormalities, specifically rearrangements (RET/PTC) or activating mutations (RAS or BRAF), are highly prevalent in papillary thyroid carcinomas (PTCs). Constitutive activation of this signaling cascade causes sustained phosphorylation of extracellular signal-regulated kinase (ERK). DUSP5, which is positively regulated by ERK signaling, acts as a negative regulator of its activity. We have previously shown that DUSP5 is overexpre...

ea0029p692 | Diabetes | ICEECE2012

Therapy with analogous of glp 1 and basal insulin in patients with diabetes mellitus type 2. Our experience.

Perez Rodriguez J. , Morales Portillo C. , Garcia Garcia C. , Fernandez Pena I. , Hernando Jimenez V. , Serrano Olmedo I. , De la Cuesta Mayor C. , Sendon Perez

Objectives: Evaluate the impact of the therapy with GLP-1 analogues (exenatide) toguether with basal insulin in glycemic control and weight of patients with type 2 diabetes mellitus poorly controlled.Materials and methods: We analyzed 37 patients with type 2 diabetes with poor glycemic control and obesity, treatment with exenatide and basal insulin. As pre-treatment 56.7% of our patients were with basal insulin, 10.8% with insulin mixtures and 32.4% with...

ea0029p1815 | Thyroid cancer | ICEECE2012

Calcitonin levels in washout of cytology needle on thyroid nodule without suspicion of medullary thyroid carcinoma

Martin T. , Garcia C. , Gonzalez N. , Sanchez P. , Barco A. , Martin V. , Sendon A.

Introduction: We study the calcitonin levels measurement in the washout of FNAB needles after sampling each thyroid nodule (FNAB-CT) as an approach to calcitonin normal value in them and distinguish of MTC and to correlate with serum CT (sCT) and cytology FNAB.Material & Methods: 109 consecutive subjects (mean age 53.7±13.4, range 18–85 yr, 79.8% females, 27.5% smokers, 18.3% autoimmune thyroid disease) initially no suspicious for MTC who u...

ea0026p591 | Clinical case reports | ECE2011

X-linked adrenomieloneuropathy presenting as Addison’s disease

Bilbao I , Yoldi A , Matteucci T , Garcia C , Aranburu M , Egana N , Alvarez-Coca M , Goena M

Introduction: It has been stimated that up to 30% of idiopathic Addison disease in young boys is due to X-linked Adrenoleukodystrophy. We report the case of a 31-year-old previously asymptomatic man, who presented with hyperpigmentation and fatigue. Investigations revealed hyponatraemia (116 mEq/l), low serum cortisol (2.6 μg/ml) and high ACTH levels (>2000 pc/ml), plasma potassium was 4.37 mEq/l. Adrenal antibodies were absent and abdominal computerized tomography sc...

ea0029p593 | Diabetes | ICEECE2012

Three novel mutations in maturity-onset diabetes of the young genes in Spain

Palmeiro R. , Luna R. , Seoane I. , Trigo C. , Sanchez P. , Lopez Y. , Penin M. , Paramo C. , Garcia-Mayor R.

Introduction: Maturity-onset diabetes of the young (MODY) is a genetically, metabolically and clinically heterogeneous subtype of diabetes mellitus characterized by an early onset, an autosomal dominant inheritance, and a primary defect in insulin secretion. They are caused by mutations in a reduced number of β-cell genes. Mutations in glucokinase gen (MODY 2) and hepatic nuclear factor 1α (HNF 1α) (MODY 3) are the most common.Materials an...

ea0029p1383 | Pituitary Clinical | ICEECE2012

No evidence for detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly

Maione L. , Garcia C. , Kallel N. , Bouchachi A. , Maison P. , Kamenicky P. , Salenave S. , Young J. , Assayag P. , Chanson P.

Context: The effects of cabergoline on cardiac valves have been extensively studied in Parkinson’s disease and hyperprolactinemia but not in acromegaly, a condition at risk of cardiac valve abnormalities.Objective: We examined the prevalence of heart valve disease and regurgitation in a series of patients with acromegaly treated with cabergoline, by comparison with matched patients who had never received this drug.Design and s...

ea0083erco2 | Endocrine-related Cancer | EYES2022

Ablation of Znrf3 & Trp53 induces metastatic adrenocortical carcinoma in mice

J. Wilmouth JR , J. Olabe , L. Landwehr , L. Pucheu , D. Dufour , F. Roucher-Boulez , C. Lucas-Rodrigues , D. Garcia-Garcia , C. Damon-Soubeyrand , M. Kroiss , M. Fassnacht , A. Lefrancois-Martinez , A. Martinez , P. Val

Background: Adrenocortical carcinoma (ACC) is an aggressive cancer originating from steroidogenic cells within the adrenal cortex. Unfortunately, half of patients present with metastatic spread upon initial diagnosis, and there is no curative therapy for advanced disease. Genomic analysis has identified that the most aggressive subgroup of ACC patients have overlapping alterations in the WNT/β-catenin pathway and the p53/RB signaling pathway.Objecti...

ea0073yi8 | Young Investigator Awards | ECE2021

Metformin and simvastatin in combination: drugs repositioning to impair high-grade astrocytomas progression

Fuentes-Fayos Antonio C. , Garcia Garcia Miguel , Jiménez-Vacas Juan M , Martin-Colom Julia , Doval-Rosa Carlos , Blanco-Acevedo Cristobal , Gahete Ortiz Manuel , Castaño Justo P. , Juan Solivera , Luque Raul M.

Astrocytomas are a subtype of malignant gliomas characterized by rapid growth and high diffusion through the brain. Based on the agresiveness features, they are stratified from low grades (I and II) to high grades (HGAs; III and IV), being grade-IV [glioblastoma multiforme (GBM)] the most aggressive and one of the most common malignant cancers in the brain, with an overall survival from diagnosis of ~14 months. Current standard therapies to treat HGAs are not efficient and the...